Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.
Satish
Bhadriraju
B
Baldwin Family Health Care, Baldwin, MI, USA. drbkm@yahoo.com
Tressa
Kellogg
K
Harish
Chandra R
CR
D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D023921:Coronary Stenosis / Q000628:therapy*; D018450:Disease Progression; D004342:Drug Hypersensitivity / Q000209:etiology*; D004359:Drug Therapy, Combination; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D015607:Stents; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology / Q000627:therapeutic use; D050257:Tubulin Modulators / Q000008:administration & dosage; D014581:Urticaria / Q000139:chemically induced*
D010975:Platelet Aggregation Inhibitors; D050257:Tubulin Modulators; D000077144:Clopidogrel; D013988:Ticlopidine; D017239:Paclitaxel; D001241:Aspirin